TEG – organizer of the most important pharmaceutical and and biotechnology business summit in CEE Pharm Connect Congress, with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) – announces the 3rd Central Eastern European Pharmaceutical Manufacturing Excellence Award. The aim of the award is not only to celebrate excellence in manufacturing, but also to encourage professionals to constantly raise standards contributing to the development as well.
Applications from all members of the industry are welcome in two categories – innovative and generic pharmaceutical and biotechnology manufacturers in the first one, while service providers with a customer project in the second until the 16th of January 2017! The winners will have the opportunity to present their projects to the top pharmaceutical and biotechnology management professionals at PHARM Connect running on 22-23 February 2017 in Budapest between the walls of the prestigious Corinthia Grand Hotel Royal.
The two-days networking event allow participants to meet fellow decision makers playing key role in pharmaceutical and biotechnology companies from all over CEE as well as take part in round table discussions, presentations, enjoy relaxed networking opportunities as a member of the greatest professional hub of the region. Heads of plants, production, packaging, quality management, R&D, sterile technologies and contamination control, technical, maintenance, logistics, distribution, CEOs and many more from the most prominent pharmaceutical and biotech companies attend regulary to sit down for one-to-one business meetings, change business cards, discuss key topics of specific industry challenges and eshtablish new and fruitfull partnerships.
Images from 2016 Pharm Connect Congress: Finesse Solution on a one-to-one meeting, Pall Life Sience meeting room
Industry pears usually have more meetings in 2 days than throughout a year, with professionals who are interested in what they have to offer!
For further information about PHARM Connect Congress please visit: www.pharmconnect.eu
